title: Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery.
abstract: The risk of thrombosis is high in patients with essential thrombocythemia. Special precaution needed for those patients who will undergo Coronary artery bypass grafting. We are reporting a 62 years old patient with ischemic heart disease who was found to have essential thrombocythemia. This report explains the preoperative management and the postoperative risks anticipated due to the treatment.
authors.affiliation: Division of Cardiothoracic Surgery, Sultan Qaboos University Hospital, Muscat, Sultanate Oman.
authors.forename: Edem
authors.initials: E
authors.lastname: Ziadinov
authors.affiliation: Division of Cardiothoracic Surgery, Sultan Qaboos University Hospital, Muscat, Sultanate Oman.
authors.forename: Hilal
authors.initials: H
authors.lastname: Al-Sabti
authors.affiliation: Division of Cardiothoracic Surgery, Sultan Qaboos University Hospital, Muscat, Sultanate Oman.
authors.forename: Malik
authors.initials: M
authors.lastname: Al-Toubi
authors.affiliation: Division of Cardiothoracic Surgery, Sultan Qaboos University Hospital, Muscat, Sultanate Oman.
authors.forename: Mohammad Salman
authors.initials: MS
authors.lastname: Siddiqi
keywords: Case Report; Coronary Artery Bypass Grafting; Essential Thrombocythemia; Hydroxyurea